Loading provider…
Loading provider…
Dermatology Physician in San Diego, CA
NPI: 1558313916Primary Employer
UCSD Medical Group
health.ucsd.edu
HQ Phone
Get M.D. Tissa's Phone Numberphone_androidMobile
Get M.D. Tissa's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1988 - 2026
UT State Medical License
1994 - 2002

American Board of Dermatology
Dermatology
Keck School of Medicine of USC
keck.usc.edu
Medical School
Until 1987
Mass General Brigham/Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's Hosp
Residency • Dermatology
1991 - 1994
UCLA-VA Greater Los Angeles
Residency • Internal Medicine
1987 - 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 708 | 979 |
| 2 | 17000Destruction of skin growth | 523 | 680 |
| 3 | 17003Destruction of 2-14 skin growths | 416 | 2,702 |
| 4 | 17110Destruction of up to 14 skin growths | 224 | 254 |
| 5 | 11102Tangential biopsy of single skin lesion | 196 | 221 |
Authors: Saisindhu Narala, Richard Gallo, Kimberly Chun
Journal: Sci Transl Med
Authors: Robert Modlin, Michael Farhangian, Joyce Cheng, Richard Gallo, Jason Seidman
Journal: J Invest Dermatol
Publication Date: 2023-07-20
Rheumatoid arthritis in dermatology.
Authors: Arthur Kavanaugh
Journal: Clin Dermatol
Lead Sponsor: Eli Lilly and Company
Collaborators: Dermira, Inc.
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: Lebrikizumab
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Sanofi, Regeneron Pharmaceuticals, Rho Federal Systems Division, Inc., Atopic Dermatitis Research Network
Intervention / Treatment: DRUG: Placebo, DRUG: Dupilumab
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Atopic Dermatitis Research Network
Intervention / Treatment: DRUG: Placebo Lotion, BIOLOGICAL: TMT Lotion